Journal article 719 views
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme / A. G. S. Warrilow; C. M. Hull; J. E. Parker; E. P. Garvey; W. J. Hoekstra; W. R. Moore; R. J. Schotzinger; D. E. Kelly; S. L. Kelly; Steven Kelly; Diane Kelly; Josie Parker; Claire Hull; Andrew Warrilow
Antimicrobial Agents and Chemotherapy, Volume: 58, Issue: 12, Pages: 7121 - 7127
Swansea University Authors: Steven, Kelly, Diane, Kelly, Josie, Parker, Claire, Hull, Andrew, Warrilow
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1128/AAC.03707-14
Abstract
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
Published in: | Antimicrobial Agents and Chemotherapy |
---|---|
Published: |
2014
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa18693 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Item Description: |
E-pub ahead of press. |
---|---|
College: |
Swansea University Medical School |
Issue: |
12 |
Start Page: |
7121 |
End Page: |
7127 |